Report cover image

iCAD Inc - Product Pipeline Analysis, 2026 Update

Publisher GlobalData
Published Apr 20, 2026
Length 46 Pages
SKU # GBDT21121797

Description

Summary
iCAD Inc (iCAD), a subsidiary of RadNet Inc, is a medical technology company that provides AI-powered cancer detection technologies. The company develops and markets solutions for cancer detection and risk assessment. The company offers cancer detection products and solutions which include Powerlook, VeraLook and ProFound AI and magnetic resonance imaging (MRI) applications for diagnostic purposes. Its major product is the ProFound Breast Health Suite, which includes solutions for breast cancer detection, density assessment, and cardiovascular risk evaluation. The company uses artificial intelligence for its product development. iCAD operates in the US and markets products through direct sales organizations, OEM partners with Google Health, distributors and resellers in the US and abroad. iCAD is headquartered in Nashua, New Hampshire, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company iCAD Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

46 Pages
iCAD Inc Company Overview
iCAD Inc Company Snapshot
iCAD Inc Pipeline Products and Ongoing Clinical Trials Overview
iCAD Inc – Pipeline Analysis Overview
Business Description
iCAD Inc - Key Facts
iCAD Inc - Major Products and Services
iCAD Inc Pipeline Products by Development Stage
iCAD Inc Pipeline Products Overview
AI - Cardiovascular Risk Detection
AI - Cardiovascular Risk Detection Product Overview
Artificial Intelligence-Based System - Breast Cancer Risk Prediction
Artificial Intelligence-Based System - Breast Cancer Risk Prediction Product Overview
Integrated Profound AI - 2D Mammography
Integrated Profound AI - 2D Mammography Product Overview
Integrated Profound AI - 3D Mammography
Integrated Profound AI - 3D Mammography Product Overview
M-Vu CAD System - Tomosynthesis
M-Vu CAD System - Tomosynthesis Product Overview
MRI-Guided Prostate Biopsy
MRI-Guided Prostate Biopsy Product Overview
ProFound AI Suite
ProFound AI Suite Product Overview
Prostate MR/TRUS-Fusion Device
Prostate MR/TRUS-Fusion Device Product Overview
Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer
Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer Product Overview
Xoft Axxent Electronic Brachytherapy System - Prostate Cancer
Xoft Axxent Electronic Brachytherapy System - Prostate Cancer Product Overview
Xoft Brain IORT System
Xoft Brain IORT System Product Overview
iCAD Inc - Key Competitors
iCAD Inc - Key Employees
iCAD Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
iCAD Inc, Recent Developments
Jul 23, 2025: FDA clears Philips’ image-guided navigation system for prostate cancer
Apr 29, 2025: iCAD Collaborates with Microsoft to Provide Access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)
Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024
Mar 05, 2025: iCAD and RamSoft Announce Partnership to Deliver ProFound AI-Powered Mammography Solutions Across North America
Feb 26, 2025: Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025
Feb 19, 2025: iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025
Dec 11, 2024: SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
Nov 26, 2024: iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
Nov 21, 2024: iCAD Receives Additional 510(K) Clearance For ProFound AI - DBT
Nov 12, 2024: iCAD's Profound Detection Version 4.0 Gains FDA Clearance
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
iCAD Inc Pipeline Products and Ongoing Clinical Trials Overview
iCAD Inc Pipeline Products by Equipment Type
iCAD Inc Pipeline Products by Indication
iCAD Inc, Key Facts
iCAD Inc, Major Products and Services
iCAD Inc Number of Pipeline Products by Development Stage
iCAD Inc Pipeline Products Summary by Development Stage
AI - Cardiovascular Risk Detection - Product Status
AI - Cardiovascular Risk Detection - Product Description
Artificial Intelligence-Based System - Breast Cancer Risk Prediction - Product Status
Artificial Intelligence-Based System - Breast Cancer Risk Prediction - Product Description
Integrated Profound AI - 2D Mammography - Product Status
Integrated Profound AI - 2D Mammography - Product Description
Integrated Profound AI - 3D Mammography - Product Status
Integrated Profound AI - 3D Mammography - Product Description
M-Vu CAD System - Tomosynthesis - Product Status
M-Vu CAD System - Tomosynthesis - Product Description
MRI-Guided Prostate Biopsy - Product Status
MRI-Guided Prostate Biopsy - Product Description
ProFound AI Suite - Product Status
ProFound AI Suite - Product Description
Prostate MR/TRUS-Fusion Device - Product Status
Prostate MR/TRUS-Fusion Device - Product Description
Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer - Product Status
Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer - Product Description
Xoft Axxent Electronic Brachytherapy System - Prostate Cancer - Product Status
Xoft Axxent Electronic Brachytherapy System - Prostate Cancer - Product Description
Xoft Brain IORT System - Product Status
Xoft Brain IORT System - Product Description
iCAD Inc, Key Employees
iCAD Inc, Subsidiaries
Glossary
List of Figures
iCAD Inc Pipeline Products by Equipment Type
iCAD Inc Pipeline Products by Development Stage

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us